Revvity Total Current Liabilities 2010-2024 | RVTY

Revvity total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Revvity total current liabilities for the quarter ending September 30, 2024 were $0.688B, a 52.49% decline year-over-year.
  • Revvity total current liabilities for 2023 were $1.45B, a 6.09% decline from 2022.
  • Revvity total current liabilities for 2022 were $1.544B, a 27.25% increase from 2021.
  • Revvity total current liabilities for 2021 were $1.214B, a 26.54% decline from 2020.
Revvity Annual Total Current Liabilities
(Millions of US $)
2023 $1,450
2022 $1,544
2021 $1,214
2020 $1,652
2019 $763
2018 $772
2017 $951
2016 $603
2015 $561
2014 $597
2013 $603
2012 $581
2011 $599
2010 $515
2009 $497
Revvity Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $688
2024-06-30 $1,390
2024-03-31 $1,374
2023-12-31 $1,450
2023-09-30 $1,448
2023-06-30 $1,367
2023-03-31 $1,564
2022-12-31 $1,544
2022-09-30 $1,486
2022-06-30 $1,044
2022-03-31 $1,263
2021-12-31 $1,214
2021-09-30 $1,145
2021-06-30 $1,123
2021-03-31 $1,521
2020-12-31 $1,652
2020-09-30 $1,245
2020-06-30 $1,163
2020-03-31 $730
2019-12-31 $763
2019-09-30 $1,188
2019-06-30 $707
2019-03-31 $742
2018-12-31 $772
2018-09-30 $687
2018-06-30 $713
2018-03-31 $926
2017-12-31 $951
2017-09-30 $598
2017-06-30 $589
2017-03-31 $601
2016-12-31 $603
2016-09-30 $548
2016-06-30 $561
2016-03-31 $555
2015-12-31 $561
2015-09-30 $554
2015-06-30 $574
2015-03-31 $551
2014-12-31 $597
2014-09-30 $567
2014-06-30 $579
2014-03-31 $605
2013-12-31 $603
2013-09-30 $589
2013-06-30 $563
2013-03-31 $573
2012-12-31 $581
2012-09-30 $582
2012-06-30 $588
2012-03-31 $603
2011-12-31 $599
2011-09-30 $876
2011-06-30 $559
2011-03-31 $511
2010-12-31 $515
2010-09-30 $514
2010-06-30 $514
2010-03-31 $498
2009-12-31 $497
2009-09-30 $513
2009-06-30 $497
2009-03-31 $469
Sector Industry Market Cap Revenue
Medical Medical Services $14.905B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.015B 12.16
Cencora (COR) United States $48.948B 18.05
DiDi Global (DIDIY) China $23.622B 0.00
ICON (ICLR) Ireland $17.731B 15.79
Natera (NTRA) United States $16.587B 0.00
Viatris (VTRS) United States $15.469B 4.76
Avantor (AVTR) United States $15.375B 23.05
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.590B 0.00
Solventum (SOLV) United States $12.509B 0.00
Medpace Holdings (MEDP) United States $11.276B 31.77
Charles River Laboratories (CRL) United States $11.014B 21.28
Doximity (DOCS) United States $10.815B 64.01
HealthEquity (HQY) United States $8.629B 46.83
Sonic Healthcare (SKHHY) Australia $8.542B 0.00
Bausch + Lomb (BLCO) Canada $7.043B 32.79
Life Times (LTH) United States $5.170B 34.22
Sotera Health (SHC) United States $4.557B 24.38
Organon (OGN) United States $4.131B 4.17
Surgery Partners (SGRY) United States $3.859B 42.76
BrightSpring Health Services (BTSG) United States $3.408B 72.48
PACS (PACS) United States $3.251B 0.00
Alignment Healthcare (ALHC) United States $2.620B 0.00
Concentras Parent (CON) United States $2.500B 0.00
Ardent Health Partners (ARDT) United States $2.337B 0.00
Premier (PINC) United States $2.292B 11.44
GeneDx Holdings (WGS) United States $2.137B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.589B 0.00
Progyny (PGNY) United States $1.499B 26.37
Pediatrix Medical (MD) United States $1.353B 13.24
Establishment Labs Holdings (ESTA) $1.292B 0.00
CareDx (CDNA) United States $1.268B 0.00
AMN Healthcare Services Inc (AMN) United States $1.104B 7.49
Embecta (EMBC) United States $0.897B 5.98
InnovAge Holding (INNV) United States $0.813B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.757B 0.00
SBC Medicals (SBC) United States $0.706B 0.00
Auna S.A (AUNA) Luxembourg $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.469B 0.00
DocGo (DCGO) United States $0.409B 15.38
Enhabit (EHAB) United States $0.397B 34.30
COMPASS Pathways (CMPS) United Kingdom $0.373B 0.00
LifeMD (LFMD) United States $0.252B 0.00
Sera Prognostics (SERA) United States $0.225B 0.00
ModivCare (MODV) United States $0.221B 12.05
Beauty Health (SKIN) United States $0.202B 0.00
Biodesix (BDSX) United States $0.199B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.129B 0.00
So-Young (SY) China $0.089B 21.63
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.055B 0.00
OncoCyte (OCX) United States $0.048B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.036B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00